Нутритивная поддержка реанимационных больных: роль липидного компонента

Закрыть метаданные

Рекомендуем статьи по данной теме:

Нутритивная поддержка при сепсисе: существует ли единая концепция?. Анестезиология и реаниматология. 2024;(6):70-78

К вопросу об оптимизации белкового и энергетического обеспечения пациентов с острым нарушением мозгового кровообращения. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2024;(8-2):51-55

Возможности специализированной диетотерапии в снижении токсических проявлений у больных метастатическим кастрационно-резистентным раком предстательной железы с метастазами в костях при проведении радионуклидной терапии радия хлоридом [223Ra]. Онкология. Журнал им. П.А. Герцена. 2024;(6):33-41

Оценка влияния комплексной реабилитационной программы на улучшение нутритивного статуса, психоэмоциональных признаков и нежелательных явлений у пациентов с меланомой после проведенного хирургического лечения. Хирургия. Журнал им. Н.И. Пирогова. 2024;(12-2):173-178

Нутритивная поддержка является важным компонентом лечения больных в критическом состоянии. Несвоевременная или неадекватная коррекция нарушений пищевого статуса сопровождается увеличением числа осложнений и показателей летальности у больных реанимационного профиля. Проведение нутритивной поддержки должно быть персонифицировано с учетом фазы критического состояния, основного заболевания, коморбидной патологии. Обеспечение больного энергетическими субстратами и пластическим материалом должно проводиться согласно действующим клиническим рекомендациям. Важным компонентом клинического питания является фармаконутриент ω-3-полиненасыщенные жирные кислоты, оказывающие противовоспалительное и иммуномодулирующее действие. Выявление новых свойств ω-3-полиненасыщенных жирных кислот, связанных с разрешением процессов воспаления, открывает многообещающие перспективы их применения. С целью изучения роли ω-3-полиненасыщенных жирных кислот в эффективности нутритивной поддержки у больных, находящихся в отделении реанимации и интенсивной терапии, выполнен анализ публикаций в медицинских базах eLibrary, PubMed, Medline (2005—2024 гг.). На основе полученных данных представлена доказательная база позитивных эффектов клинического питания с применением препаратов, в состав которых входят ω-3-полиненасыщенные жирные кислоты, у больных сепсисом, при остром повреждении легких, полиорганной недостаточности, новой коронавирусной инфекции.

Ключевые слова:

нутритивная поддержка

критическое состояние

ω-3-полиненасыщенные жирные кислоты

ω-3-ПНЖК

Авторы:

Пасечник И.Н.

ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации

ORCID: 0000-0002-8121-4160

Талызин П.А.

ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации;
ГБУЗ города Москвы «Городская клиническая больница им. М.Е. Жадкевича Департамента здравоохранения города Москвы»

ORCID: 0000-0001-8333-8354

Скобелев Е.И.

ORCID: 0000-0003-2815-5277

Дата поступления:

28.02.2024

Дата принятия в печать:

13.03.2024

Список литературы:

Lopez-Fermin J, Escarramán-Martínez D, Flores Ramírez R. Doing More Can Be Worse: Ten Common Errors in the ICU. ICU Management and Practice. 2022;22(1):28-32.
Ng DHL, Koh FHX, Yeong HEL, Huey TCW, Chue KM, Foo FJ, Chew STH. Nutrition Care after Hospital Discharge in Singapore: Evidence-Based Best-Practice Recommendations. Nutrients. 2023;15(21):4492. https://doi.org/10.3390/nu15214492
Пасечник И.Н. Нутритивная поддержка больных в критических состояниях (обзор). Общая реаниматология. 2020;16(4):40-59. https://doi.org/10.15360/1813-9779-2020-4-40-59
Herridge MS, Moss M, Hough CL, Hopkins RO, Rice TW, Bienvenu OJ, Azoulay E. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Medicine. 2016;42(5):725-738. https://doi.org/10.1007/s00134-016-4321-8
Cotoia A, Umbrello M, Ferrari F, Pota V, Alessandri F, Cortegiani A, De Rosa S. Nutritional support and prevention of post-intensive care syndrome: the Italian SIAARTI survey. Journal of Anesthesia, Analgesia and Critical Care. 2023;3(1):45. https://doi.org/10.1186/s44158-023-00132-4
Wischmeyer PE. Enteral Nutrition Can Be Given to Patients on Vasopressors. Critical Care Medicine. 2020;48(1):122-125. https://doi.org/10.1097/CCM.0000000000003965
Singer P, Blaser AR, Berger MM, Calder PC, Casaer M, Hiesmayr M, Mayer K, Montejo-Gonzalez JC, Pichard C, Preiser JC, Szczeklik W, van Zanten ARH, Bischoff SC. ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit. Clinical Nutrition. 2023;42(9):1671-1689. https://doi.org/10.1016/j.clnu.2023.07.011
Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Oczkowski S, Szczeklik W, Bischoff SC. ESPEN guideline on clinical nutrition in the intensive care unit. Clinical Nutrition. 2019;38(1):48-79. https://doi.org/10.1016/j.clnu.2018.08.037
Compher C, Bingham AL, McCall M, Patel J, Rice TW, Braunschweig C, McKeever L. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition. Journal of Parenteral and Enteral Nutrition. 2022;46(1):12-41. https://doi.org/10.1002/jpen.2267
Hill A, Elke G, Weimann A. Nutrition in the Intensive Care Unit — A Narrative Review. Nutrients. 2021;13(8):2851. https://doi.org/10.3390/nu13082851
Gomes F, Schuetz P, Bounoure L. ESPEN guidelines on nutritional support for polymorbid internal medicine patients. Clinical Nutrition. 2018;37(1): 336-353. https://doi.org/10.1016/j.clnu.2017.06.025
Лейдерман И.Н., Грицан А.И., Заболотских И.Б., Лебединский К.М., Крылов К.Ю., Мазурок В.А., Ярошецкий А.И. Метаболический мониторинг и нутритивная поддержка при проведении длительной искусственной вентиляции легких. Анестезиология и реаниматология. 2022;5:6-17. https://doi.org/10.17116/anaesthesiology20220516
Лейдерман И.Н., Грицан А.И., Заболотских И.Б., Мазурок В.А., Поляков И.В., Потапов А.Л., Сытов А.В., Ярошецкий А.И. Периоперационная нутритивная поддержка. Методические рекомендации Федерации анестезиологов и реаниматологов. Вестник интенсивной терапии им. А.И. Салтанова. 2021;4:7-20. https://doi.org/10.21320/1818-474X-2021-4-7-20
Ершов В.И., Новикова Т.В. Три основных компонента стартовой энтеральной поддержки пациентов неврологического профиля при критических состояниях. Анестезиология и реаниматология. 2023;6:84-90. https://doi.org/10.17116/anaesthesiology202306184
Berger MM, Reintam-Blaser A, Calder PC, Casaer M, Hiesmayr MJ, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Bischoff SC, Singer P. Monitoring nutrition in the ICU. Clinical Nutrition. 2019;38(2):584-593. https://doi.org/10.1016/j.clnu.2018.07.009
Jiang L, Huang X, Wu C. The effects of an enteral nutrition feeding protocol on critically ill patients: A prospective multi-center, before-after study. Journal of Critical Care. 2020;56:249-256. https://doi.org/10.1016/j.jcrc.2020.01.018
Li Y, Liu H. Application strategy and effect analysis of nutritional support nursing for critically ill patients in intensive care units. Medicine. 2022;101(38):e30396. https://doi.org/10.1097/MD.0000000000030396
Canales C, Elsayes A, Yeh DD, Belcher D, Nakayama A. Nutrition Risk in Critically Ill Versus the Nutritional Risk Screening 2002: Are They Comparable for Assessing Risk of Malnutrition in Critically Ill Patients? Journal of Parenteral and Enteral Nutrition. 2019;43(1):81-87. https://doi.org/10.1002/jpen.1181
Coruja MK, Cobalchini Y, Wentzel C, Fink JDS. Nutrition Risk Screening in Intensive Care Units: Agreement Between NUTRIC and NRS 2002 Tools. Nutrition in Clinical Practice. 2020;35(3):567-571. https://doi.org/10.1002/ncp.10419
Rattanachaiwong S, Zribi B, Kagan I, Theilla M, Heching M, Singer P. Comparison of nutritional screening and diagnostic tools in diagnosis of severe malnutrition in critically ill patients. Clinical Nutrition. 2020;S0261-5614(20)30099-6. https://doi.org/10.1016/j.clnu.2020.02.035
Moonen HPFX, Beckers KJH, van Zanten ARH. Energy expenditure and indirect calorimetry in critical illness and convalescence: current evidence and practical considerations. Journal of the Intensive Care. 2021;9(1):8. https://doi.org/10.1186/s40560-021-00524-0
Heyland DK, Patel J, Compher C, Rice TW, Bear DE, Lee ZY, González VC, O’Reilly K, Regala R, Wedemire C, Ibarra-Estrada M, Stoppe C, Ortiz-Reyes L, Jiang X, Day AG; EFFORT Protein Trial team. The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial. Lancet. 2023;401(10376):568-576. https://doi.org/10.1016/S0140-6736(22)02469-2
De Waele E, van Zanten ARH. Routine use of indirect calorimetry in critically ill patients: pros and cons. Critical Care. 2022;26(1):123. https://doi.org/10.1186/s13054-022-04000-5
Van Zanten ARH, De Waele E, Wischmeyer PE. Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases. Critical Care. 2019;23:368.
Koekkoek WACK, van Setten CHC, Olthof LE, Kars JCNH, van Zanten ARH. Timing of PROTein INtake and clinical outcomes of adult critically ill patients on prolonged mechanical VENTilation: The PROTINVENT retrospective study. Clinical Nutrition. 2019;38(2):883-890. https://doi.org/10.1016/j.clnu.2018.02.012
Пасечник И.Н., Закревский А.И. Нутритивная поддержка и реабилитация в отделениях реанимации и интенсивной терапии больных пожилого и старческого возраста. Обзор литературы. Вестник интенсивной терапии им. А.И. Салтанова. 2021;2:94-102. https://doi.org/10.21320/1818-474X-2021-2-94-102
Пасечник И.Н., Сирота А.Е., Талызин П.А., Новикова Т.В. Особенности нутритивной поддержки при стрессовой гипергликемии и сахарном диабете в отделении реанимации и интенсивной терапии. Анестезиология и реаниматология. 2023;3:59-66. https://doi.org/10.17116/anaesthesiology202303159
Wischmeyer PE, Bear DE, Berger MM, De Waele E, Gunst J, McClave SA, Prado CM, Puthucheary Z, Ridley EJ, Van den Berghe G, van Zanten ARH. Personalized nutrition therapy in critical care: 10 expert recommendations. Critical Care. 2023;27(1):261. https://doi.org/10.1186/s13054-023-04539-x
Cintoni M, Mele MC. The Role of Immunonutrition in Patients. Nutrients. 2023;15(3):780. https://doi.org/10.3390/nu15030780
Tao X, Yang Y, Xu S, Xiong Q. Efficacy of immune nutrients in severe acute pancreatitis: A network meta-analysis. Medicine. 2023;102(43):e35615. https://doi.org/10.1097/MD.0000000000035615
McCarthy MS, Martindale RG. Immunonutrition in Critical Illness: What Is the Role? Nutrition in Clinical Practice. 2018;33(3):348-358. https://doi.org/10.1002/ncp.10102
Hirschberger S, Schmid A, Kreth S. Immunomodulation by nutritional intervention in critically ill patients. Anaesthesiologie. 2023;72(4):229-244. https://doi.org/10.1007/s00101-023-01258-4
Пасечник И.Н., Губайдуллин Р.Р., Борисов А.Ю. Основы нутритивной поддержки больных в критических состояниях. М.: РИА «Колизей»; 2012.
Jeyakumar SM, Vajreswari A. Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids. World Journal of Clinical Cases. 2021;9(31):9333-9349. https://doi.org/10.12998/wjcc.v9.i31.9333
De Waele E, Malbrain MLNG, Spapen H. Nutrition in Sepsis: A Bench-to-Bedside Review. Nutrients. 2020;12(2):395. https://doi.org/10.3390/nu12020395
Singer P, Calder PC. The role of omega-3 polyunsaturated fatty acids in the intensive care unit. Current Opinion in Clinical Nutrition and Metabolic Care. 2023;26(2):129-137. https://doi.org/10.1097/MCO.0000000000000896
Blaauw R, Calder PC, Martindale RG, Berger MM. Combining proteins with n-3 PUFAs (EPA+DHA) and their infammation pro-resolution mediators for preservation of skeletal muscle mass. Critical Care. 2024;28:38. https://doi.org/10.1186/s13054-024-04803-8
Cagnina RE, Duvall MD, Nijmeh J, Levy BD. Specialized pro-resolving mediators in respiratory diseases. Current Opinion in Clinical Nutrition and Metabolic Care. 2022;25(2):67-74. https://doi.org/10.1097/MCO.0000000000000805
Saini RK, Keum Y-S. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance — A review. Life Science. 2018;203:255-267. https://doi.org/10.1016/j.lfs.2018.04.049
Schulze MB, Minihane AM, Saleh RNM, Risérus U. Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases. Lancet Diabetes and Endocrinology. 2020;8(11):915-930. https://doi.org/10.1016/S2213-8587(20)30148-0
Djuricic I, Calder PC. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021. Nutrients. 2021;13(7):2421. https://doi.org/10.3390/nu13072421
Kapoor B, Kapoor D, Gautam S, Singh R, Bhardwaj S. Dietary Polyunsaturated Fatty Acids (PUFAs): Uses and Potential Health Benefits. Current Nutrition Reports. 2021;10(3):232-242. https://doi.org/10.1007/s13668-021-00363-3
Oppedisano F, Macrì R, Gliozzi M, Musolino V, Carresi C, Maiuolo J, Bosco F, Nucera S, Caterina Zito M, Guarnieri L, Scarano F, Nicita C, Coppoletta AR, Ruga S, Scicchitano M, Mollace R, Palma E, Mollace V. The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection. Biomedicines. 2020;8(9):306. https://doi.org/10.3390/biomedicines8090306
Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedecine and Pharmacotherapie. 2002;56(8):365-379. https://doi.org/10.1016/s0753-3322(02)00253-6
Heller AR, Rössler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine. 2006;34(4):972-979. https://doi.org/10.1097/01.CCM.0000206309.83570.45
Martin JM, Stapleton RD. Omega-3 fatty acids in critical illness. Nutrition Reviews. 2010;68(9):531-541. https://doi.org/10.1111/j.1753-4887.2010.00313.x
Darwesh AD, Bassiouni W, Sosnowski DK, Seubert JM. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? Pharmacology and Therapeutics. 2021;219:107703. https://doi.org/10.1016/j.pharmthera.2020.107703
Zhang Y, Guo H, Liang J, Xiao W, Li Y. Relationship between Dietary Omega-3 and Omega-6 Polyunsaturated Fatty Acids Level and Sarcopenia. A Meta-Analysis of Observational Studies. Frontiers in Nutrition. 2022;8:738083. https://doi.org/10.3389/fnut.2021.738083
Ломиворотов В. В., Ефремов С. М., Абубакиров М. Н., Стоппе Х. Осталось ли место омега-3 жирным кислотам в кардиохирургии? Вестник анестезиологии и реаниматологии. 2017;14(3):51-57. https://doi.org/10.21292/2078-5658-2017-14-3-51-57
Vijai KSS. Correcting ω6/ω3 Ratio through Combating Oxidation is the Key to the Success for Better Health. Annals of Reviews and Research. 2018;2(4): 555591.
Kazuo M. Prevention of Fish Oil Oxidation. Journal of Oleo Science. 2019; 68(1):1-11. https://doi.org/10.5650/jos.ess18144
Yang A, Wu Y, Yu G, Wang H. Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development. Respiratory Research. 2021;22(1):204. https://doi.org/10.1186/s12931-021-01792-y
Serhan CN, Dalli J, Colas RA, Winkler JW, Chiang N. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochimica Biophysica Acta. 2015;1851(4):397-413. https://doi.org/10.1016/j.bbalip.2014.08.006
Molfino A, Amabile MI, Monti M, Muscaritoli M. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both? Oxidative Medicine and Cellular Longevity. 2017;2017:5987082. https://doi.org/10.1155/2017/5987082
Kumar V, Fausto N, Abbas AK. Robbins and Cotran Pathologic Basis of Disease. 8-th ed. Elsevier/Saunders; 2010.
Julliard WA, Myo YPA, Perelas A. Specialized pro-resolving mediators as modulators of immune responses. Seminars in Immunology. 2022;59:101605. https://doi.org/10.1016/j.smim.2022.101605
Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. The Journal of Clinical Investigation. 2018;128(7):2657-2669. https://doi.org/10.1172/JCI97943
Ferreira I, Falcato F, Bandarra N, Rauter AP. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation. Molecules. 2022;27(5):1677. https://doi.org/10.3390/molecules27051677
Chiang N, Serhan CN. Specialized pro-resolving mediator network: an update on production and actions. Essays in Biochemistry. 2020;64(3):443-462. https://doi.org/10.1042/EBC20200018
Jordan PM, Werz O. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections. FEBS Journal. 2022;289(14):4212-4227. https://doi.org/10.1111/febs.16266
Shimizu T, Saito T, Aoki-Saito H, Okada S, Ikeda H, Nakakura T, Fukuda H, Arai S, Fujiwara K, Nakajima Y, Horiguchi K, Yamada S, Ishida E, Hisada T, Shuto S, Yamada M. Resolvin E3 ameliorates high-fat diet-induced insulin resistance via the phosphatidylinositol-3-kinase/Akt signaling pathway in adipocytes. FASEB Journal. 2022;36(3):e22188. https://doi.org/10.1096/fj.202100053R
Jiang JH, Hassan KA, Begg SL, Rupasinghe TWT, Naidu V, Pederick VG, Khorvash M, Whittall JJ, Paton JC, Paulsen IT, McDevitt CA, Peleg AY, Eijkelkamp BA. Identification of Novel Acinetobacter baumannii Host Fatty Acid Stress Adaptation Strategies. mBio. 2019;10(1):e02056-18. https://doi.org/10.1128/mBio.02056-18
Zang M, Adams FG, Hassan KA, Eijkelkamp BA. The Impact of Omega-3 Fatty Acids on the Evolution of Acinetobacter baumannii Drug Resistance. Microbiology Spectrum. 2021;9(3):e0145521. https://doi.org/10.1128/Spectrum.01455-21
Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Loiacono R, Loggi E, de Biase D, Zippi M, Lari F, Zancanaro M. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Prostaglandins and other Lipid Mediators. 2022;159:106619. https://doi.org/10.1016/j.prostaglandins.2022.106619
Yasmeen N, Selvaraj H, Lakhawat SS, Datta M, Sharma PK, Jain A, Khanna R, Srinivasan J, Kumar V. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. Biochemical Pharmacology. 2023;209:115437. https://doi.org/10.1016/j.bcp.2023.115437
Calder PC. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake. Biochimie. 2020;178:105-123. https://doi.org/10.1016/j.biochi.2020.08.015
Pradelli L, Mayer K, Klek S, Omar Alsaleh AJ, Clark RAC, Rosenthal MD, Heller AR, Muscaritoli M. ω-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta-Analysis and Trial Sequential Analysis. Journal of Parenteral and Enteral Nutrition. 2020;44(1):44-57. https://doi.org/10.1002/jpen.1672
Pradelli L, Klek S, Mayer K, Omar Alsaleh AJ, Rosenthal MD, Heller AR, Muscaritoli M. Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis. Critical Care. 2020;24(1):634. https://doi.org/10.1186/s13054-020-03356-w
Wang C, Han D, Feng X, Wu J. Omega-3 fatty acid supplementation is associated with favorable outcomes in patients with sepsis: an updated meta-analysis. Journal of International Medical Research. 2020;48(12):300060520953684. https://doi.org/10.1177/0300060520953684
Wang H, Su S, Wang C, Hu J, Dan W, Peng X. Effects of fish oil-containing nutrition supplementation in adult sepsis patients: A systematic review and meta-analysis. Burns and Trauma. 2022;10:tkac012. https://doi.org/10.1093/burnst/tkac012
Zhu D, Zhang Y, Li S, Gan L, Feng H, Nie W. Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Intensive Care Medicine. 2014;40(4):504-512. https://doi.org/10.1007/s00134-014-3244-5
Langlois PL, D’Aragon F, Hardy G, Manzanares W. Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Nutrition. 2019;61:84-92. https://doi.org/10.1016/j.nut.2018.10.026
Huang Z, Zheng J, Huang W, Yan M, Hong L, Hong Y, Jin R, Huang X, Fan H, Chen H, Yang H, Su W, Huang X. The effects and safety of omega-3 fatty for acute lung injury: a systematic review and meta-analysis. World Journal of Surgical Oncology. 2020;18(1):235. https://doi.org/10.1186/s12957-020-01916-6
Koekkoek WK, Panteleon V, van Zanten AR. Current evidence on ω-3 fatty acids in enteral nutrition in the critically ill: A systematic review and meta-analysis. Nutrition. 2019;59:56-68. https://doi.org/10.1016/j.nut.2018.07.013
Naghibi T, Shafigh N, Mazloomzadeh S. Role of omega-3 fatty acids in the prevention of delirium in mechanically ventilated patients. Journal of Research in Medical Sciences. 2020;25:10. https://doi.org/10.4103/jrms.JRMS_567_18
Doaei S, Gholami S, Rastgoo S, Gholamalizadeh M, Bourbour F, Bagheri SE, Samipoor F, Akbari ME, Shadnoush M, Ghorat F, Mosavi Jarrahi SA, Ashouri Mirsadeghi N, Hajipour A, Joola P, Moslem A, Goodarzi MO. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: A randomized clinical trial. Journal of Translational Medicine. 2021;19(1):128. https://doi.org/10.1186/s12967-021-02795-5
Wu S-C, Chen T-A, Tsai I-J, Wang Y-C, Cheng H-T, Tzeng C-W, Hsu C-H, Muo C-H. Lipid-Free Parenteral Nutrition Is Associated with an Increased Risk of Hepatic Dysfunction in Surgical Critically Ill Patients: A Retrospective Observational Study. Healthcare. 2021;9(9):1096. https://doi.org/10.3390/healthcare9091096

Закрыть метаданные